Following the well-attended EACPT international summer school in 2013 in Edinburgh, the next European Association for Clinical Pharmacology and Therapeutics [EACPT] update for young researchers is the 2014 EACPT Focus Meeting on ‘Drugs to Fight Cardiovascular Damage’.
The 2014 EACPT Focus Meeting takes place from July 3rd – 5th at the Radboud University Medical
 |
| Radboud University Medical Centre, Nijmegen |
Center in Nijmegen in the Netherlands.
This EACPT cardiovascular focus meeting is of interest to clinical pharmacologists, pharmacologists, and other young scientists and clinicians interested in drug treatment of cardiovascular disease.
Topics include:
– ultrasound imaging of vascular injury (including a workshop tproviding t hands-on training),
– the microbiome and inflammation in the metabolic syndrome
– targeting inflammation to prevent and treat atherosclerosis
– diagnosis and therapy of adrenal hypertension
– protection against ischaemia-reperfusion injury.
Provisional State of the Art Lectures by invited speakers include:
Arterial stiffness measurements; methods and relevance for risk assessment and drug-research: Stephane Laurent, Paris, France
IMT measurement with ultrasound, methods and relevance for risk assessment and drug research: Luc van Bortel, Gent, Belgium
The microbiome in the pathogenesis of metabolic syndrome: Max Nieuwdorp
Fat cells and inflammation in the pathogenesis of the Metabolic Syndrome: Rinke Stienstra, Nijmegen, The Netherlands
Predicting and manipulating drug inactivation by the human gut microbiome: H. Haiser. FAS Center for Systems Biology, Harvard University, USA
Cardiac protection by conditioning: from bench to bedside: D. Hausenloy, Hatter Institute, London
The role of hexokinase in cardioprotection: C. Zuurbier, Amsterdam, The Netherlands
Wnt pathways in cardiac repair and remodeling: M. Blankesteijn
Targeting the adaptive immune system in atherosclerosis: Esther Lutgens, AMC, Amsterdam
Trained immunity in the pathogenesis of atherosclerosis: Niels Riksen, Nijmegen, The Netherlands
The pathogenesis of autonomous adrenal aldosterone release: Felix Beuschlein
Diagnosis and treatment of hyperaldosteronism: Jaap Deinum, Nijmegen, The Netherlands
Health professional scientists, academics and professionals from the pharmaceutical, biotechnology, and related sectors are invited to submit their latest scientific results for oral or poster presentation.
Abstract submission and registration will open shortly on our dedicated website.
Comments:0